Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SAP vs MRNA✓SelectedUSD · MRNASAP vs MRNA performance historyLatest closeAs of-2.12%11/20
Stock and ETF performance explorer

SAP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+59.2%
MRNA return
-27.3%
Excess return
+86.4%
Maximum drawdown
-52.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.1%-2.2%+0.1%-2.0%
7D-15.3%-12.7%-2.6%-14.9%
30D-14.5%-20.7%+6.1%-13.9%
3M-8.4%+46.3%-54.6%-10.2%
6M+10.6%+305.2%-294.7%-1.4%
YTD-16.7%+561.2%-577.9%-30.2%
1Y-13.5%+772.1%-785.6%-29.9%
3Y+34.9%+147.0%-112.1%+19.8%
All+59.2%-27.3%+86.4%+47.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling